SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle's recent earnings have sparked significant discussion, with the community debating whether the numbers justify the stock's valuation and future prospects. Despite positive metrics, concerns linger around debt levels, heavy capital expenditures, and the sustainability of AI-driven growth. Community members are closely watching how Oracle navigates these challenges and whether it can maintain its position in the competitive cloud and AI landscape.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is trending due to ongoing speculation and uncertainty surrounding its bid for Warner Bros. Discovery, with community members debating the deal's potential impact on the stock's value and regulatory hurdles. Some traders believe the stock is oversold and poised for a bounce, while others worry about the financial implications of a potential acquisition and are closely monitoring developments in the media landscape.

Gemini Space Station, Inc. is a holding company, which offers a mobile and web based crypto asset exchange platform, proprietary wallet infrastructure and custody solutions, over-the-counter trading solutions tailored to institutions and professionals, a digital art auction platform, a proprietary United States dollar backed stablecoin, and a credit card product that offers crypto asset rewards on customer purchases. The company was founded by Tyler Winklevoss and Cameron Winklevoss in 2014 and is headquartered in New York, NY.

Gemini Space Station Inc. - Ordinary Shares- Class A

Gemini Space Station

GEMI is trending following news of Gemini receiving a CFTC license to operate prediction markets, a process that took five years, giving them a competitive edge. The community is discussing the potential for a short squeeze due to high short interest and the significance of this license for long-term growth. Some are comparing GEMI to other companies in the prediction market space, anticipating a possible increase in value.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

CRML is trending amid discussions about the rare earth elements sector, with attention focused on a joint venture in Romania and its potential to impact European manufacturing and security. Community talking points revolve around the implications of the deal and the anticipated release of the Bank Feasibility Study (BFS). Some investors express concerns about project timelines and government involvement, while others remain optimistic about the company's long-term prospects and its role in challenging China's dominance in the rare earth market.

Beasley Broadcast Group, Inc. is multi-platform media company, which engages in the operation of radio stations in the United States. The firm offers marketing solutions across event platforms. It operates through the following business segments: Audio, Digital, and Other. The company was founded by George G. Beasley in 1961 and is headquartered in Naples, FL.

Beasley Broadcast Group Inc - Ordinary Shares - Class A

BBGI is trending due to a volatile surge, with community members debating whether it can sustain its gains, mirroring past high-flying stocks like SMX. Discussions revolve around its potential for another run, overnight action, and strategies for profit-taking. Some traders are also pointing to the relatively small float, suggesting potential for significant price swings.

Yee is a community based memecoin with one mission: to fight Pepe again. Made to honor the iconic meme rivalry we all know and love.  The Yee Legend  [Filed by: Yee’s Archivist & Legal Representative]  There’s something the meme world refuses to talk about: Pepe the Frog stole Yee the Dino’s entire launch plan.  Yee had been preparing for his comeback for months, but Pepe launched two weeks earlier, hijacking Yee’s concept and selling it as his own.  The charges? Meme theft, intellectual forgery, and historical erasure.  Yee’s official contract was filed in April 2023, right after Pepe’s surprise drop. This wasn’t timing—it was theft. The archives are about to open, and history is about to be corrected

Yee Token

$YEE is gaining attention as community members rally around the token, citing a strong narrative and increased momentum. Some users are drawing comparisons to other successful meme coins and highlighting its potential within the ETH ecosystem. The community emphasizes a long-term vision and encourages others to study $YEE's unique story.

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

Novo Nordisk is trending as the community discusses its potential as an undervalued defensive stock amid AI bubble concerns and GLP-1 competition. Some speculate about imminent news or a drug approval catalyst, while others point to technical patterns and potential Congressional support. Bullish sentiment revolves around Novo Nordisk's prospects in the weight loss market and potential for a significant price increase.

Mawson Infrastructure Group, Inc. engages in the provision of digital asset infrastructure services. The company was founded on February 10, 2012 and is headquartered in Midland, PA.

Mawson Infrastructure Group Inc

MIGI is trending due to its potential as a low-float runner in the crypto sector, with traders anticipating significant moves tied to its digital infrastructure and AI GPU hosting plans. The community is focused on the company's conference presentation and potential catalysts, like expansion updates or new contracts, which could trigger a short squeeze given the limited share availability. MIGI's transformation from a miner to a broader infrastructure player is also generating discussion, with some believing it's undervalued relative to its peers.

Planet Labs PBC provides daily data and insights about earth. It offers a web-geo platform with satellite data available and foundational analytics to derive insights to make decisions. The company is founded by William S. Marshall and Robert H. Schingler in 2010 and is headquartered in San Francisco, CA.

Planet Labs PBC - Ordinary Shares - Class A

Planet Labs PBC

Planet Labs is trending following strong Q3 earnings that beat expectations and positive guidance, fueling optimism around the company's growth trajectory. The community is particularly excited about the acquisition of Bedrock Research and potential applications of AI-powered geospatial data, as well as upcoming launches to expand satellite capabilities. Renewed investor enthusiasm in the aerospace sector, especially around space-based data centers, adds to the positive sentiment.

Adobe, Inc. is a global technology company, which engages in the provision of digital marketing and media solutions. It operates through the following segments: Digital Media, Digital Experience, and Publishing and Advertising. The Digital Media segment offers products and services that enable individuals, teams, businesses, and enterprises to create, publish, and promote content anywhere and accelerate productivity by transforming view, share, engage with and collaborate on documents and creative content. The Digital Experience segment focuses on integrated platform and set of products, services, and solutions that enable businesses to create, manage, execute, measure, monetize, and optimize customer experiences that span from analytics to commerce. The Publishing and Advertising segment includes legacy products and services that address diverse market opportunities, including eLearning solutions, technical document publishing, web conferencing, document and forms platform, web app development, high-end printing, and Adobe Advertising offerings. The company was founded by Charles M. Geschke and John E. Warnock in December 1982 and is headquartered in San Jose, CA.

Adobe Inc

Adobe's recent earnings beat couldn't lift the stock, sparking debate about AI's impact on its creative empire and competition from firms like Figma. While some investors highlight Adobe's AI integration, strong financials, and buyback program, others worry about slowing growth and disruption, leading to a mixed sentiment within the community.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Tenaya Therapeutics, Inc. (NASDAQ:TNYA) Receives Consensus Recommendation of "Moderate Buy" from Brokerages

Shares of Tenaya Therapeutics, Inc. (NASDAQ:TNYA - Get Free Report) have received a consensus rating of "Moderate Buy" from the five analysts that are covering the company, Marketbeat Ratings...

Chardan Capital Issues Optimistic Forecast for TNYA Earnings

Tenaya Therapeutics, Inc. (NASDAQ:TNYA - Free Report) - Equities researchers at Chardan Capital boosted their FY2025 EPS estimates for shares of Tenaya Therapeutics in a research note issued to...

Tenaya Therapeutics (NASDAQ:TNYA) Releases Quarterly Earnings Results

Tenaya Therapeutics (NASDAQ:TNYA - Get Free Report) posted its earnings results on Monday. The company reported ($0.12) earnings per share for the quarter, topping analysts' consensus estimates of...

Tenaya Therapeutics (NASDAQ:TNYA) Receives Buy Rating from Chardan Capital

Chardan Capital restated a "buy" rating and issued a $9.00 target price on shares of Tenaya Therapeutics in a research note on Monday...

Tenaya Therapeutics, Inc. (NASDAQ:TNYA) Receives Average Rating of "Moderate Buy" from Analysts

Shares of Tenaya Therapeutics, Inc. (NASDAQ:TNYA - Get Free Report) have received a consensus rating of "Moderate Buy" from the five ratings firms that are presently covering the firm, MarketBeat.com...

Tenaya Therapeutics (NASDAQ:TNYA) Stock Price Down 2.2% - Time to Sell?

Tenaya Therapeutics (NASDAQ:TNYA) Trading Down 2.2% - Time to Sell...

Mineralys Therapeutics Inc. (123% jump in watchers)The clinical-stage biopharmaceutical company saw the highest jump in retail interest after reporting positive topline data from its Phase 3 and Phase 2 trials for lorundrostat in treating uncontrolled hypertension (uHTN) and resistant hypertension (rHTN). Both trials met their primary efficacy endpoints, showing statistically significant blood pressure reductions.&nbsp;The company also announced a $250 million underwritten public offering to fund lorundrostat’s development and pre-commercialization efforts.Mineralys stock is up over 15% year-to-date (YTD).Tenaya Therapeutics Inc. (11% jump in watchers)Tenaya saw increased attention after reporting stronger-than-expected fourth-quarter earnings and highlighting upcoming clinical data readouts for its gene therapy programs targeting cardiomyopathies.&nbsp;CEO Faraz Ali noted continued progress in the TN-201 MyPEAK-1 and TN-401 RIDGE-1 trials.&nbsp;Tenaya’s stock remains down over 53% YTD.SpringWorks Therapeutics Inc. (10% jump in watchers)SpringWorks gained traction amid ongoing&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/swtx-sees-biggest-weekly-biotech-jump-in-stocktwits-following/cheUZARRbb2">speculation</a> about a potential buyout by Merck KGaA. While Merck confirmed advanced merger discussions in its annual report, it stopped short of announcing a deal, leaving traders searching for clues. The company’s withdrawal from a Barclays healthcare conference further fueled speculation.&nbsp;SpringWorks stock is up more than 40% YTD.COSCIENS Biopharma Inc. (9% jump in watchers)COSCIENS initiated a Phase 2a clinical efficacy trial for its avenanthramides product, which is being explored for its anti-inflammatory properties. The trial, dubbed the AvenActive study, will assess safety and efficacy in two dosage arms.&nbsp;COSCIENS stock has gained over 20% YTD.Metagenomi Inc. (7% jump in watchers)Metagenomi published new research in Nature Communications on its novel CAST gene editing system, which enables precise, programmable integration of large gene cargoes. The technology could have major implications for treating genetic diseases like cystic fibrosis and Duchenne Muscular Dystrophy.&nbsp;Metagenomi stock is down more than 46% YTD.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Hand holding test tube over stock data on computer monitor. | Image source: Getty Images

Mineralys, Tenaya, SpringWorks, COSCIENS, Metagenomi: 5 Biotech Stocks That Led Retail Follower Growth Last Week

Positive data from clinical trials, earnings readouts, M&A speculation and new research drew heavy interest from retail traders on Stocktwits for these tickers for the week ended March 14, 2025.  

Equity

Positive data from clinical trials, earnings readouts, M&A speculation and new research drew heavy interest from retail traders on Stocktwits for these tickers for the week ended March 14, 2025.  


Tenaya Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of therapeutics for cardiovascular diseases. Its programs include TN-201, TN-401, and TN-301. The company was founded by Deepak Srivastava, Benoit G. Bruneau, Bruce R. Conklin, Sheng Ding, Saptarsi Haldar, and Eric Newell Olson in 2016 and is headquartered in South San Francisco, CA.

Tenaya Therapeutics Inc

Bullish: S&P grinds higher

Choppy but up: buy dips

Sideways: fade the move

Bearish: this rally falls off

The Federal Reserve just announced a 0.25 percentage point interest rate cut at its December 10, 2025 meeting.​ Share your outlook on how the latest Federal Reserve interest rate cut will impact stocks and the S&P 500 over the next month.

How do you think today’s Fed rate cut impacts stocks over the next month?

Current Price	$1.40
Prev Close	$1.41
Open	$1.43
Dividend Yield	0.00%
50-Day Moving Average	$1.52
Beta	2.13
Avg. Volume	2.83M
PE Ratio	-1.78

52-Week High	$3.69
52-Week Low	$0.36
Market Capitalization	$234.77M
EPS (Annual)	-$1.31
Price to Book	2.77
Revenue Per Employee	$0.00
Enterprise Value/EBITDA	N/A

TNYA
Tenaya Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest TNYA News

TNYATenaya Therapeutics Inc